Please assess the completion status of the following clinical trial:

Trial Title: Group-based or Individual Information About Disease and Treatment Plan

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Breast cancer patients that are candidates for adjuvant chemotherapy after surgery.~* Prostate cancer patients that are candidates for curative radiotherapy~* Signed informed consent~* Patient expected to be able to complete the planned treatment and the study procedures~* 18years or older~Exclusion Criteria:~-Patients not fulfilling inclusion criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group and Individual information (Type: EXPERIMENTAL): The patients will receive two 1.5-2 hour standardized validated group information sessions in addition to regular information from their doctors and nurses.
- Individual information (Type: NO_INTERVENTION): Standard information about disease and treatment from doctor and nurse given at 2 occasions.

Based on this trial design, predict the completion outcome and termination type (if applicable).